用hCG 200 iu 取代FSH於晚期誘導排卵

卵>1.2cm可以使用hCG 200 iu/d 取代FSH於誘導排卵

http://molehr.oxfordjournals.org/content/17/1/33.full

Table I

Baseline characteristics and cycle outcome measures^a.

	rFSH standard treatment group	Low-dose hCG treatment group	P-value for between-group differencec
Age, yearsa	30.4 (4.0)	30.5 (2.5)	0.94
Weight, kga	62.5 (9.8)	62.2 (7.3)	0.93
Height, cma	164 (7)	168 (4)	0.10
BMI, kg/m2a	23.3 (2.6)	22.1 (2.7)	0.26
FSH, IU/la	6.2 (1.3)	7.3 (1.8)	0.08
LH, IU/la	5.2 (2.3)	5.5 (2.3)	0.75
E2, pg/mla	42.0 (16.4)	43.1 (23.7)	0.90
Progesterone ng/mla	0.7 (0.2)	0.6 (0.2)	0.22
Total dose of rFSH, IUa	1693 (281)	1218 (244)	<0.001
Overall treatment duration, daysa	8.4 (1.4)	8.2 (1.4)	0.72
rFSH duration, daysa	8.4 (1.4)	6.1 (1.2)	<0.001
hCG duration, daysa	0	2.1 (0.5)	<0.001
Number of COCsa	11.1 (4.0)	13.8 (8.6)	0.29
Number of M II oocytesa	8.4 (3.4)	9.8 (5.0)	0.40
Number of 2-PN oocytesa	6.7 (3.3)	8.7 (4.7)	0.21
Number of patients with positive hCGb	1	3
Per started cycle	1/17	3/15	0.23
Per pickup	1/15	3/11	0.15
Per embryo transfer	1/13	3/8	0.09

• ^aMean values per patient (SD).
• ^bData are presented as number of cases.
• ^cP-values for t-test for independent samples; significant P-values <0.001 are bold.